{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:51:56Z","timestamp":1791341516054,"version":"4.3.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00253-020-11050-8","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T16:03:10Z","timestamp":1612022590000},"page":"1421-1434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells"],"prefix":"10.1007","volume":"105","author":[{"given":"Yixiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bissinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Genzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Song","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,30]]},"reference":[{"issue":"1","key":"11050_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/1097-0290(20001005)70:1<25::AID-BIT4>3.0.CO;2-Q","volume":"70","author":"DC Andersen","year":"2000","unstructured":"Andersen DC, Bridges T, Gawlitzek M, Hoy C (2000) Multiple cell culture factors can affect the glycosylation of asn-184 in CHO-produced tissue-type plasminogen activator. Biotechnol Bioeng 70(1):25\u201331","journal-title":"Biotechnol Bioeng"},{"issue":"2\u20133","key":"11050_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10616-007-9093-0","volume":"55","author":"S Ansorge","year":"2007","unstructured":"Ansorge S, Esteban G, Schmid G (2007) On-line monitoring of infected Sf-9 insect cell cultures by scanning permittivity measurements and comparison with off-line biovolume measurements. Cytotechnology 55(2\u20133):115\u2013124. https:\/\/doi.org\/10.1007\/s10616-007-9093-0","journal-title":"Cytotechnology"},{"issue":"6","key":"11050_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/bit.21364","volume":"97","author":"MG Aucoin","year":"2007","unstructured":"Aucoin MG, Perrier M, Kamen AA (2007) Improving AAV vector yield in insect cells by modulating the temperature after infection. Biotechnol Bioeng 97(6):1501\u20131509. https:\/\/doi.org\/10.1002\/bit.21364","journal-title":"Biotechnol Bioeng"},{"issue":"47","key":"11050_CR4","doi-asserted-by":"publisher","first-page":"7003","DOI":"10.1016\/j.vaccine.2019.04.054","volume":"37","author":"T Bissinger","year":"2019","unstructured":"Bissinger T, Fritsch J, Mihut A, Wu Y, Liu X, Genzel Y, Tan W-S, Reichl U (2019) Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production. Vaccine 37(47):7003\u20137010. https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.054","journal-title":"Vaccine"},{"issue":"50","key":"11050_CR5","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1016\/j.vaccine.2018.10.072","volume":"36","author":"H Boigard","year":"2018","unstructured":"Boigard H, Cimica V, Galarza JM (2018) Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature. Vaccine 36(50):7728\u20137736. https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.072","journal-title":"Vaccine"},{"issue":"1\u20133","key":"11050_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10616-005-3974-x","volume":"50","author":"JP Carvell","year":"2006","unstructured":"Carvell JP, Dowd JE (2006) On-line measurements and control of viable cell density in cell culture manufacturing processes using radio-frequency impedance. Cytotechnology 50(1\u20133):35\u201348. https:\/\/doi.org\/10.1007\/s10616-005-3974-x","journal-title":"Cytotechnology"},{"issue":"35","key":"11050_CR7","doi-asserted-by":"publisher","first-page":"14802","DOI":"10.1073\/pnas.0905912106","volume":"106","author":"C Chu","year":"2009","unstructured":"Chu C, Lugovtsev V, Golding H, Betenbaugh M, Shiloach J (2009) Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production. PNAS 106(35):14802\u201314807 www.pnas. https:\/\/doi.org\/10.1073\/pnas.0905912106","journal-title":"PNAS"},{"issue":"47","key":"11050_CR8","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1016\/j.vaccine.2019.06.005","volume":"37","author":"J Coronel","year":"2019","unstructured":"Coronel J, Behrendt I, Burgin T, Anderlei T, Sandig V, Reichl U, Genzel Y (2019) Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems. Vaccine 37(47):7011\u20137018. https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.005","journal-title":"Vaccine"},{"issue":"1","key":"11050_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/btpr.1601","volume":"29","author":"P Emma","year":"2013","unstructured":"Emma P, Kamen A (2013) Real-time monitoring of influenza virus production kinetics in HEK293 cell cultures. Biotechnol Prog 29(1):275\u2013284. https:\/\/doi.org\/10.1002\/btpr.1601","journal-title":"Biotechnol Prog"},{"key":"11050_CR10","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1086\/507550","volume":"194","author":"AS Fauci","year":"2006","unstructured":"Fauci AS (2006) Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 194:S73\u2013S76","journal-title":"J Infect Dis"},{"key":"11050_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/978-1-59745-399-8_21","volume-title":"Vaccine production animal cell biotechnology: methods and protocols","author":"Y Genzel","year":"2007","unstructured":"Genzel Y, Reichl U (2007) Vaccine Production. In: Vaccine production animal cell biotechnology: methods and protocols, 2rd edn. Humana Press, Totowa, pp 457\u2013473","edition":"2"},{"issue":"12","key":"11050_CR12","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1586\/erv.09.128","volume":"8","author":"Y Genzel","year":"2009","unstructured":"Genzel Y, Reichl U (2009) Continuous cell lines as a production system for influenza vaccines. Expert Rev Vaccines 8(12):1681\u20131692","journal-title":"Expert Rev Vaccines"},{"issue":"24","key":"11050_CR13","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.vaccine.2014.02.016","volume":"32","author":"Y Genzel","year":"2014","unstructured":"Genzel Y, Vogel T, Buck J, Behrendt I, Ramirez DV, Schiedner G, Jordan I, Reichl U (2014) High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells. Vaccine 32(24):2770\u20132781. https:\/\/doi.org\/10.1016\/j.vaccine.2014.02.016","journal-title":"Vaccine"},{"key":"11050_CR14","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/bit.260280912","volume":"28","author":"M Glacken","year":"1986","unstructured":"Glacken M, Fleischaker R, Sinskey A (1986) Reduction of waste product excretion via nutrient control: possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells. Biotechnol Bioeng 28:1376\u20131389. https:\/\/doi.org\/10.1002\/bit.260280912","journal-title":"Biotechnol Bioeng"},{"issue":"47","key":"11050_CR15","doi-asserted-by":"publisher","first-page":"7019","DOI":"10.1016\/j.vaccine.2019.04.030","volume":"37","author":"G Granicher","year":"2019","unstructured":"Granicher G, Coronel J, Pralow A, Marichal-Gallardo P, Wolff M, Rapp E, Karlas A, Sandig V, Genzel Y, Reichl U (2019) Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1. Vaccine 37(47):7019\u20137028. https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.030","journal-title":"Vaccine"},{"issue":"7","key":"11050_CR16","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/bit.20074","volume":"86","author":"O Henry","year":"2004","unstructured":"Henry O, Dormond E, Perrier M, Kamen A (2004) Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Biotechnol Bioeng 86(7):765\u2013774","journal-title":"Biotechnol Bioeng"},{"key":"11050_CR17","doi-asserted-by":"publisher","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A, M\u00fcller MA, Drosten C, P\u00f6hlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271-280.e8 https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","DOI":"10.1016\/j.cell.2020.02.052"},{"issue":"1","key":"11050_CR18","doi-asserted-by":"publisher","first-page":"e14578","DOI":"10.1371\/journal.pone.0014578","volume":"6","author":"AY Hu","year":"2011","unstructured":"Hu AY, Tseng YF, Weng TC, Liao CC, Wu J, Chou AH, Chao HJ, Gu A, Chen J, Lin SC, Hsiao CH, Wu SC, Chong P (2011) Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium. PLoS One 6(1):e14578. https:\/\/doi.org\/10.1371\/journal.pone.0014578","journal-title":"PLoS One"},{"issue":"11","key":"11050_CR19","doi-asserted-by":"publisher","first-page":"e0141686","DOI":"10.1371\/journal.pone.0141686","volume":"10","author":"D Huang","year":"2015","unstructured":"Huang D, Peng WJ, Ye Q, Liu XP, Zhao L, Fan L, Xia-Hou K, Jia HJ, Luo J, Zhou LT, Li BB, Wang SL, Xu WT, Chen Z, Tan WS (2015) Serum-free suspension culture of MDCK cells for production of influenza H1N1 vaccines. PLoS One 10(11):e0141686. https:\/\/doi.org\/10.1371\/journal.pone.0141686","journal-title":"PLoS One"},{"issue":"35","key":"11050_CR20","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1016\/j.vaccine.2012.05.065","volume":"30","author":"B Isken","year":"2012","unstructured":"Isken B, Genzel Y, Reichl U (2012) Productivity, apoptosis, and infection dynamics of influenza A\/PR\/8 strains and A\/PR\/8-based reassortants. Vaccine 30(35):5253\u20135261. https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.065","journal-title":"Vaccine"},{"key":"11050_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1021\/bp025585a","volume":"19","author":"M Jardon","year":"2003","unstructured":"Jardon M, Garnier A (2003) pH, pCO2 temperature effect on R-adenovirus production. Biotechnol Prog 19:202\u2013208","journal-title":"Biotechnol Prog"},{"key":"11050_CR22","doi-asserted-by":"publisher","unstructured":"Jia X, Li Y, Fan W, Sun Q, Zhou T, Lin W, Li J (2016) Effects of temperature and pH on the growth of H1N1 subtype of influenza A virus by surface-enhanced Raman spectroscopy. Sheng Wu Gong Cheng Xue Bao 32(4):447-456 https:\/\/doi.org\/10.13345\/j.cjb.150362","DOI":"10.13345\/j.cjb.150362"},{"issue":"3","key":"11050_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.biologicals.2007.10.002","volume":"36","author":"B Kalbfuss","year":"2008","unstructured":"Kalbfuss B, Kn\u00f6chlein A, Kr\u00f6ber T, Reichl U (2008) Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity. Biologicals 36(3):145\u2013161. https:\/\/doi.org\/10.1016\/j.biologicals.2007.10.002","journal-title":"Biologicals"},{"issue":"4","key":"11050_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3311\/PPch.8824","volume":"60","author":"B Kiss","year":"2016","unstructured":"Kiss B, N\u00e9meth \u00c1 (2016) Application of a high cell density capacitance sensor to different microorganisms. Period Polytech-Chem 60(4):290\u2013297. https:\/\/doi.org\/10.3311\/PPch.8824","journal-title":"Period Polytech-Chem"},{"key":"11050_CR25","first-page":"101","volume":"98","author":"O Kistner","year":"1999","unstructured":"Kistner O, Barrett P, Mundt W, Reiter M, Schober-Bendixen S, Eder G, Dorner F (1999) Development of a Vero cell-derived influenza whole virus vaccine. Dev Biol Stand 98:101\u2013110","journal-title":"Dev Biol Stand"},{"key":"11050_CR26","doi-asserted-by":"crossref","unstructured":"Konstantinov K, Goudar C, Ng M, Meneses R, Thrift J, Chuppa S, Matanguihan C, Michaels J, Naveh D (2006) The \u201cpush-to-low\u201d approach for optimization of high-density perfusion cultures of animal cells cell culture engineering. Adv Biochem Engin\/Biotechnol, pp:75\u201398","DOI":"10.1007\/10_016"},{"key":"11050_CR27","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1056\/NEJMra1002842","volume":"363","author":"LC Lambert","year":"2010","unstructured":"Lambert LC, Fauci AS (2010) Influenza vaccines for the future. New Engl J Med 363:2036\u20132044. https:\/\/doi.org\/10.1056\/NEJMra1002842","journal-title":"New Engl J Med"},{"issue":"2","key":"11050_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/bit.10773","volume":"84","author":"L Maranga","year":"2003","unstructured":"Maranga L, Brazao TF, Carrondo MJ (2003) Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system. Biotechnol Bioeng 84(2):245\u2013253. https:\/\/doi.org\/10.1002\/bit.10773","journal-title":"Biotechnol Bioeng"},{"issue":"45","key":"11050_CR29","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.1016\/j.vaccine.2016.08.019","volume":"34","author":"KA McLean","year":"2016","unstructured":"McLean KA, Goldin S, Nannei C, Sparrow E, Torelli G (2016) The 2015 global production capacity of seasonal and pandemic influenza vaccine. Vaccine 34(45):5410\u20135413. https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.019","journal-title":"Vaccine"},{"key":"11050_CR30","first-page":"23","volume":"98","author":"OW Merten","year":"1999","unstructured":"Merten OW, Manuguerra JC, Hannoun C, van der Werf S (1999) Production of influenza virus in serum-free mammalian cell cultures. Dev Biol Stand 98:23\u201337","journal-title":"Dev Biol Stand"},{"issue":"43","key":"11050_CR31","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1016\/j.vaccine.2019.08.064","volume":"37","author":"K Nakamura","year":"2019","unstructured":"Nakamura K, Harada Y, Takahashi H, Trusheim H, Bernhard R, Hamamoto I, Hirata-Saito A, Ogane T, Mizuta K, Konomi N, Konomi Y, Asanuma H, Odagiri T, Tashiro M, Yamamoto N (2019) Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus. Vaccine 37(43):6526\u20136534. https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.064","journal-title":"Vaccine"},{"issue":"20","key":"11050_CR32","doi-asserted-by":"publisher","first-page":"8725","DOI":"10.1007\/s00253-018-9275-z","volume":"102","author":"A Nikolay","year":"2018","unstructured":"Nikolay A, Leon A, Schwamborn K, Genzel Y, Reichl U (2018) Process intensification of EB66 cell cultivations leads to high-yield yellow fever and Zika virus production. Appl Microbiol Biotechnol 102(20):8725\u20138737. https:\/\/doi.org\/10.1007\/s00253-018-9275-z","journal-title":"Appl Microbiol Biotechnol"},{"issue":"48","key":"11050_CR33","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1016\/j.vaccine.2013.09.051","volume":"31","author":"B Peschel","year":"2013","unstructured":"Peschel B, Frentzel S, Laske T, Genzel Y, Reichl U (2013) Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line. Vaccine 31(48):5693\u20135699. https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.051","journal-title":"Vaccine"},{"key":"11050_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jbiotec.2016.11.010","volume":"242","author":"E Petiot","year":"2017","unstructured":"Petiot E, Ansorge S, Rosa-Calatrava M, Kamen A (2017) Critical phases of viral production processes monitored by capacitance. J Biotechnol 242:19\u201329. https:\/\/doi.org\/10.1016\/j.jbiotec.2016.11.010","journal-title":"J Biotechnol"},{"issue":"4","key":"11050_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jbiotec.2010.09.959","volume":"150","author":"J Rodriguez","year":"2010","unstructured":"Rodriguez J, Spearman M, Tharmalingam T, Sunley K, Lodewyks C, Huzel N, Butler M (2010) High productivity of human recombinant beta-interferon from a low-temperature perfusion culture. J Biotechnol 150(4):509\u2013518. https:\/\/doi.org\/10.1016\/j.jbiotec.2010.09.959","journal-title":"J Biotechnol"},{"issue":"5","key":"11050_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/bit.21057","volume":"95","author":"H Sandberg","year":"2006","unstructured":"Sandberg H, Lutkemeyer D, Kuprin S, Wrangel M, Almstedt A, Persson P, Ek V, Mikaelsson M (2006) Mapping and partial characterization of proteases expressed by a CHO production cell line. Biotechnol Bioeng 95(5):961\u2013971. https:\/\/doi.org\/10.1002\/bit.21057","journal-title":"Biotechnol Bioeng"},{"issue":"2","key":"11050_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4049\/jimmunol.1002664","volume":"186","author":"K Sun","year":"2011","unstructured":"Sun K, Ye J, Perez DR, Metzger DW (2011) Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J Immunol 186(2):987\u2013993. https:\/\/doi.org\/10.4049\/jimmunol.1002664","journal-title":"J Immunol"},{"issue":"8","key":"11050_CR38","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.vaccine.2013.11.044","volume":"32","author":"F Tapia","year":"2014","unstructured":"Tapia F, Vogel T, Genzel Y, Behrendt I, Hirschel M, Gangemi JD, Reichl U (2014) Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine 32(8):1003\u20131011. https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.044","journal-title":"Vaccine"},{"issue":"5","key":"11050_CR39","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00253-015-7267-9","volume":"100","author":"F Tapia","year":"2016","unstructured":"Tapia F, Vazquez-Ramirez D, Genzel Y, Reichl U (2016) Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production. Appl Microbiol Biotechnol 100(5):2121\u20132132. https:\/\/doi.org\/10.1007\/s00253-015-7267-9","journal-title":"Appl Microbiol Biotechnol"},{"issue":"7","key":"11050_CR40","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s00253-019-09694-2","volume":"103","author":"D Vazquez-Ramirez","year":"2019","unstructured":"Vazquez-Ramirez D, Jordan I, Sandig V, Genzel Y, Reichl U (2019) High titer MVA and influenza A virus production using a hybrid fed-batch\/perfusion strategy with an ATF system. Appl Microbiol Biotechnol 103(7):3025\u20133035. https:\/\/doi.org\/10.1007\/s00253-019-09694-2","journal-title":"Appl Microbiol Biotechnol"},{"key":"11050_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbiotec.2015.05.010","volume":"213","author":"J Walther","year":"2015","unstructured":"Walther J, Godawat R, Hwang C, Abe Y, Sinclair A, Konstantinov K (2015) The business impact of an integrated continuous biomanufacturing platform for recombinant protein production. J Biotechnol 213:3\u201312. https:\/\/doi.org\/10.1016\/j.jbiotec.2015.05.010","journal-title":"J Biotechnol"},{"issue":"10","key":"11050_CR42","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1007\/s00705-017-3460-8","volume":"162","author":"H Wang","year":"2017","unstructured":"Wang H, Guo S, Li Z, Xu X, Shao Z, Song G (2017) Suspension culture process for H9N2 avian influenza virus (strain Re-2). Arch Virol 162(10):3051\u20133059. https:\/\/doi.org\/10.1007\/s00705-017-3460-8","journal-title":"Arch Virol"},{"issue":"5","key":"11050_CR43","first-page":"133","volume":"35","author":"P Xie","year":"2019","unstructured":"Xie P, Ye Q, Liu XP, Tan WS (2019) Development of maintenance medium using for influenza virus production and analysis of cellular metabolic characteristics. Biotechnol Bull 35(5):133\u2013139","journal-title":"Biotechnol Bull"},{"issue":"2","key":"11050_CR44","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41591-018-0340-z","volume":"25","author":"S Yamayoshi","year":"2019","unstructured":"Yamayoshi S, Kawaoka Y (2019) Current and future influenza vaccines. Nat Med 25(2):212\u2013220. https:\/\/doi.org\/10.1038\/s41591-018-0340-z","journal-title":"Nat Med"},{"issue":"3","key":"11050_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/bit.20353","volume":"89","author":"SK Yoon","year":"2005","unstructured":"Yoon SK, Choi SL, Song JY, Lee GM (2005) Effect of culture pH on erythropoietin production by Chinese hamster ovary cells grown in suspension at 32.5 and 37.0 degrees C. Biotechnol Bioeng 89(3):345\u2013356. https:\/\/doi.org\/10.1002\/bit.20353","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"11050_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jviromet.2004.03.011","volume":"120","author":"R Youil","year":"2004","unstructured":"Youil R, Su Q, Toner TJ, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Kiseleva I, Shaw AR, DiStefano D (2004) Comparative study of influenza virus replication in Vero and MDCK cell lines. J Virol Methods 120(1):23\u201331. https:\/\/doi.org\/10.1016\/j.jviromet.2004.03.011","journal-title":"J Virol Methods"}],"updated-by":[{"DOI":"10.1007\/s00253-021-11286-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000}}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-020-11050-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-020-11050-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-020-11050-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:44:05Z","timestamp":1744181045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-020-11050-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["11050"],"URL":"https:\/\/doi.org\/10.1007\/s00253-020-11050-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00253-021-11286-y","asserted-by":"object"}]},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00253-021-11286-y","URL":"https:\/\/doi.org\/10.1007\/s00253-021-11286-y","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Wen-Song Tan and Xuping Liu are affiliated as directors with Shanghai BioEngine Sci-Tech and were involved in the development of the Xeno-CDM medium both for scientific and commercial purposes. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}